Trade Raffles Medical - BSLsg CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.0168 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.021193% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.000725% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | SGD | ||||||||
Margin | 5% | ||||||||
Stock exchange | Singapore | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Raffles Medical Group Ltd ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 1.0467 |
Open* | 1.0567 |
1-Year Change* | -24.28% |
Day's Range* | 1.0567 - 1.0866 |
52 wk Range | 1.01-1.52 |
Average Volume (10 days) | 2.50M |
Average Volume (3 months) | 31.52M |
Market Cap | 2.00B |
P/E Ratio | 13.77 |
Shares Outstanding | 1.86B |
Revenue | 755.08M |
EPS | 0.08 |
Dividend (Yield %) | 3.58491 |
Beta | 0.75 |
Next Earnings Date | Feb 26, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 7, 2023 | 1.0666 | 0.0000 | 0.00% | 1.0666 | 1.0666 | 1.0567 |
Dec 6, 2023 | 1.0766 | 0.0199 | 1.88% | 1.0567 | 1.0866 | 1.0567 |
Dec 4, 2023 | 1.0467 | 0.0100 | 0.96% | 1.0367 | 1.0467 | 1.0367 |
Dec 1, 2023 | 1.0367 | 0.0099 | 0.96% | 1.0268 | 1.0367 | 1.0267 |
Nov 30, 2023 | 1.0267 | -0.0100 | -0.96% | 1.0367 | 1.0367 | 1.0168 |
Nov 29, 2023 | 1.0467 | -0.0100 | -0.95% | 1.0567 | 1.0567 | 1.0467 |
Nov 28, 2023 | 1.0567 | 0.0100 | 0.96% | 1.0467 | 1.0567 | 1.0467 |
Nov 27, 2023 | 1.0567 | 0.0000 | 0.00% | 1.0567 | 1.0567 | 1.0567 |
Nov 24, 2023 | 1.0467 | 0.0100 | 0.96% | 1.0367 | 1.0467 | 1.0367 |
Nov 23, 2023 | 1.0467 | -0.0100 | -0.95% | 1.0567 | 1.0567 | 1.0467 |
Nov 22, 2023 | 1.0467 | -0.0100 | -0.95% | 1.0567 | 1.0567 | 1.0467 |
Nov 20, 2023 | 1.0666 | 0.0000 | 0.00% | 1.0666 | 1.0666 | 1.0567 |
Nov 17, 2023 | 1.0666 | 0.0099 | 0.94% | 1.0567 | 1.0666 | 1.0567 |
Nov 16, 2023 | 1.0666 | 0.0000 | 0.00% | 1.0666 | 1.0666 | 1.0567 |
Nov 15, 2023 | 1.0766 | 0.0199 | 1.88% | 1.0567 | 1.0766 | 1.0567 |
Nov 14, 2023 | 1.0467 | 0.0000 | 0.00% | 1.0467 | 1.0467 | 1.0367 |
Nov 10, 2023 | 1.0467 | 0.0100 | 0.96% | 1.0367 | 1.0567 | 1.0367 |
Nov 9, 2023 | 1.0567 | 0.0200 | 1.93% | 1.0367 | 1.0567 | 1.0367 |
Nov 8, 2023 | 1.0267 | 0.0199 | 1.98% | 1.0068 | 1.0267 | 1.0068 |
Nov 7, 2023 | 1.0068 | -0.0299 | -2.88% | 1.0367 | 1.0367 | 1.0068 |
Raffles Medical Events
Time (UTC) | Country | Event |
---|---|---|
Monday, February 26, 2024 | ||
Time (UTC) 00:30 | Country SG
| Event Full Year 2023 Raffles Medical Group Ltd Earnings Release Full Year 2023 Raffles Medical Group Ltd Earnings ReleaseForecast -Previous - |
Friday, April 26, 2024 | ||
Time (UTC) 07:30 | Country SG
| Event Raffles Medical Group Ltd Annual Shareholders Meeting Raffles Medical Group Ltd Annual Shareholders MeetingForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 766.537 | 723.791 | 568.203 | 522.038 | 489.135 |
Revenue | 766.537 | 723.791 | 568.203 | 522.038 | 489.135 |
Cost of Revenue, Total | 126.556 | 143.27 | 135.775 | 110.969 | 99.518 |
Gross Profit | 639.981 | 580.521 | 432.428 | 411.069 | 389.617 |
Total Operating Expense | 570.691 | 602.485 | 479.761 | 445.87 | 404.9 |
Selling/General/Admin. Expenses, Total | 344.56 | 390.212 | 295.637 | 274.059 | 259.514 |
Depreciation / Amortization | 40.216 | 39.326 | 35.495 | 29.26 | 18.273 |
Other Operating Expenses, Total | 42.147 | 36.147 | 12.854 | 31.582 | 30.99 |
Operating Income | 195.846 | 121.306 | 88.442 | 76.168 | 84.235 |
Interest Income (Expense), Net Non-Operating | -4.142 | -5.722 | -4.003 | -0.244 | -0.101 |
Net Income Before Taxes | 191.704 | 115.584 | 84.439 | 75.924 | 84.134 |
Net Income After Taxes | 143.702 | 83.716 | 64.67 | 60.522 | 70.803 |
Minority Interest | -0.186 | 0.455 | 1.221 | -0.249 | 0.253 |
Net Income Before Extra. Items | 143.516 | 84.171 | 65.891 | 60.273 | 71.056 |
Net Income | 143.516 | 84.171 | 65.891 | 60.273 | 71.056 |
Income Available to Common Excl. Extra. Items | 143.516 | 84.171 | 65.891 | 60.273 | 71.056 |
Income Available to Common Incl. Extra. Items | 143.516 | 84.171 | 65.891 | 60.273 | 71.056 |
Diluted Net Income | 143.516 | 84.171 | 65.891 | 60.273 | 71.056 |
Diluted Weighted Average Shares | 1866.35 | 1876.46 | 1840.37 | 1815.81 | 1788.29 |
Diluted EPS Excluding Extraordinary Items | 0.0769 | 0.04486 | 0.0358 | 0.03319 | 0.03973 |
Dividends per Share - Common Stock Primary Issue | 0.038 | 0.018 | 0.025 | 0.025 | 0.025 |
Diluted Normalized EPS | 0.0843 | 0.04433 | 0.03794 | 0.03326 | 0.04 |
Interest Expense (Income) - Net Operating | -3.395 | ||||
Unusual Expense (Income) | 17.212 | -6.47 |
Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|---|
Total revenue | 370.85 | 384.233 | 409.739 | 379.976 | 343.815 |
Revenue | 370.85 | 384.233 | 409.739 | 379.976 | 343.815 |
Cost of Revenue, Total | 92 | 65.467 | 77.057 | 72.129 | 71.141 |
Gross Profit | 278.85 | 318.766 | 332.682 | 307.847 | 272.674 |
Total Operating Expense | 294.184 | 274.764 | 323.517 | 314.733 | 287.752 |
Selling/General/Admin. Expenses, Total | 163.291 | 146.85 | 197.71 | 205.197 | 185.015 |
Depreciation / Amortization | 19.022 | 19.59 | 20.626 | 20.846 | 18.48 |
Interest Expense (Income) - Net Operating | |||||
Unusual Expense (Income) | 17.296 | ||||
Other Operating Expenses, Total | 19.871 | 25.561 | 28.124 | 16.561 | 13.116 |
Operating Income | 76.666 | 109.469 | 86.222 | 65.243 | 56.063 |
Interest Income (Expense), Net Non-Operating | 1.76 | -1.248 | -2.894 | -3.25 | -2.472 |
Net Income Before Taxes | 78.426 | 108.221 | 83.328 | 61.993 | 53.591 |
Net Income After Taxes | 60.417 | 83.74 | 59.833 | 44.876 | 38.84 |
Minority Interest | -0.566 | 0.105 | -0.291 | -0.15 | 0.605 |
Net Income Before Extra. Items | 59.851 | 83.845 | 59.542 | 44.726 | 39.445 |
Net Income | 59.851 | 83.845 | 59.542 | 44.726 | 39.445 |
Income Available to Common Excl. Extra. Items | 59.851 | 83.845 | 59.542 | 44.726 | 39.445 |
Income Available to Common Incl. Extra. Items | 59.851 | 83.845 | 59.542 | 44.726 | 39.445 |
Diluted Net Income | 59.851 | 83.845 | 59.542 | 44.726 | 39.445 |
Diluted Weighted Average Shares | 1870.14 | 1863.62 | 1869.07 | 1882.52 | 1870.4 |
Diluted EPS Excluding Extraordinary Items | 0.032 | 0.04499 | 0.03186 | 0.02376 | 0.02109 |
Dividends per Share - Common Stock Primary Issue | 0 | 0.038 | 0 | 0.018 | 0 |
Diluted Normalized EPS | 0.03206 | 0.05266 | 0.03188 | 0.02425 | 0.01858 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 460.257 | 439.099 | 331.13 | 246.006 | 198.525 |
Cash and Short Term Investments | 253.127 | 264.988 | 203.114 | 151.826 | 105.984 |
Cash & Equivalents | |||||
Total Receivables, Net | 194.032 | 160.737 | 113.429 | 83.935 | 83.221 |
Accounts Receivable - Trade, Net | 194.032 | 160.737 | 113.429 | 83.935 | 83.221 |
Total Inventory | 13.098 | 13.374 | 14.587 | 10.245 | 9.32 |
Total Assets | 1497.7 | 1545.29 | 1404.13 | 1284.82 | 1116.29 |
Property/Plant/Equipment, Total - Net | 739.072 | 797.362 | 739.905 | 685.585 | 565.716 |
Property/Plant/Equipment, Total - Gross | 908.471 | 959.927 | 879.784 | 819.76 | 674.788 |
Accumulated Depreciation, Total | -169.399 | -162.565 | -139.879 | -134.175 | -109.072 |
Goodwill, Net | 11.15 | 18.322 | 21.233 | 23.835 | 24.423 |
Intangibles, Net | 9.124 | 13.508 | 12.911 | 13.619 | 12.864 |
Long Term Investments | 273.4 | 274 | 294.6 | 311.16 | 311.16 |
Note Receivable - Long Term | 2.274 | 1.857 | 3.285 | 3.452 | 2.59 |
Other Long Term Assets, Total | 2.425 | 1.138 | 1.07 | 1.165 | 1.011 |
Total Current Liabilities | 325.7 | 416.611 | 279.924 | 218.953 | 186.329 |
Payable/Accrued | 223.771 | 253.568 | 191.382 | 162.53 | 136.789 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 19.326 | 106.54 | 38.736 | 19.301 | 19.307 |
Other Current Liabilities, Total | 82.603 | 56.503 | 49.806 | 37.122 | 30.233 |
Total Liabilities | 482.648 | 584.492 | 505.138 | 443.929 | 315.8 |
Total Long Term Debt | 76.817 | 91.592 | 166.157 | 181.075 | 97.189 |
Long Term Debt | 63.376 | 77.914 | 143.859 | 156.559 | 97.189 |
Deferred Income Tax | 8.303 | 10.147 | 7.746 | 7.014 | 4.765 |
Minority Interest | 15.35 | 15.826 | 15.401 | 15.961 | 16.137 |
Other Liabilities, Total | 56.478 | 50.316 | 35.91 | 20.926 | 11.38 |
Total Equity | 1015.05 | 960.794 | 898.996 | 840.893 | 800.489 |
Common Stock | 432.379 | 426.346 | 420.966 | 393.47 | 365.332 |
Retained Earnings (Accumulated Deficit) | 606.22 | 512.222 | 463.172 | 441.519 | 424.921 |
Unrealized Gain (Loss) | 16.367 | 16.367 | 16.367 | 16.367 | 16.367 |
Other Equity, Total | -13.018 | 9.089 | -1.109 | -10.063 | -6.131 |
Total Liabilities & Shareholders’ Equity | 1497.7 | 1545.29 | 1404.13 | 1284.82 | 1116.29 |
Total Common Shares Outstanding | 1854.55 | 1868.29 | 1864.73 | 1827.94 | 1797.17 |
Cash | 83.159 | 99.152 | 44.753 | 52.108 | 61.406 |
Short Term Investments | 169.968 | 165.836 | 158.361 | 99.718 | 44.578 |
Capital Lease Obligations | 13.441 | 13.678 | 22.298 | 24.516 | |
Treasury Stock - Common | -26.894 | -3.23 | -0.4 | -0.4 |
Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|---|
Total Current Assets | 503.907 | 460.257 | 432.309 | 439.099 | 358.517 |
Cash and Short Term Investments | 300.695 | 253.127 | 289.067 | 264.988 | 215.741 |
Cash & Equivalents | 300.695 | 253.127 | 289.067 | 264.988 | 215.741 |
Total Receivables, Net | 190.298 | 194.032 | 130.682 | 160.737 | 128.279 |
Accounts Receivable - Trade, Net | 190.298 | 194.032 | 130.682 | 160.737 | 128.279 |
Total Inventory | 12.914 | 13.098 | 12.56 | 13.374 | 14.497 |
Total Assets | 1522.81 | 1497.7 | 1518.86 | 1545.29 | 1455.09 |
Property/Plant/Equipment, Total - Net | 720.022 | 739.072 | 777.775 | 797.362 | 763.52 |
Intangibles, Net | 7.987 | 9.124 | 12.136 | 31.83 | 35.132 |
Long Term Investments | 273.4 | 273.4 | 274 | 274 | 294.6 |
Note Receivable - Long Term | 2.348 | 2.274 | 3.313 | 1.857 | 2.172 |
Other Long Term Assets, Total | 4.3 | 2.425 | 1.243 | 1.138 | 1.147 |
Total Current Liabilities | 414.694 | 325.7 | 404.253 | 416.611 | 318.25 |
Payable/Accrued | 260.517 | 223.771 | 243.622 | 253.568 | 207.487 |
Notes Payable/Short Term Debt | 87.656 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 21.4 | 19.326 | 86.224 | 106.54 | 49.177 |
Other Current Liabilities, Total | 45.121 | 82.603 | 74.407 | 56.503 | 61.586 |
Total Liabilities | 523.871 | 482.648 | 573.114 | 584.492 | 544.256 |
Total Long Term Debt | 71.594 | 76.817 | 89.623 | 91.592 | 162.65 |
Long Term Debt | 60.312 | 63.376 | 77.914 | 77.914 | 145.036 |
Capital Lease Obligations | 11.282 | 13.441 | 11.709 | 13.678 | 17.614 |
Deferred Income Tax | 9.418 | 8.303 | 10.615 | 10.147 | 7.68 |
Minority Interest | 15.747 | 15.35 | 16.093 | 15.826 | 15.358 |
Other Liabilities, Total | 12.418 | 56.478 | 52.53 | 50.316 | 40.318 |
Total Equity | 998.941 | 1015.05 | 945.745 | 960.794 | 910.832 |
Common Stock | 438.623 | 432.379 | 430.777 | 426.346 | 423.176 |
Retained Earnings (Accumulated Deficit) | 594.613 | 606.22 | 521.306 | 512.222 | 466.228 |
Treasury Stock - Common | -26.894 | -26.894 | -26.787 | -3.23 | 0 |
Unrealized Gain (Loss) | 16.367 | 16.367 | 16.367 | 16.367 | 16.367 |
Other Equity, Total | -23.768 | -13.018 | 4.082 | 9.089 | 5.061 |
Total Liabilities & Shareholders’ Equity | 1522.81 | 1497.7 | 1518.86 | 1545.29 | 1455.09 |
Total Common Shares Outstanding | 1860.33 | 1854.55 | 1852.44 | 1868.29 | 1867.56 |
Goodwill, Net | 10.848 | 11.15 | 18.083 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 143.702 | 83.716 | 64.67 | 60.522 | 70.803 |
Cash From Operating Activities | 196.225 | 160.112 | 133.146 | 111.147 | 91.528 |
Cash From Operating Activities | 37.513 | 36.725 | 33.487 | 27.65 | 17.172 |
Amortization | 2.703 | 2.601 | 2.008 | 1.61 | 1.101 |
Non-Cash Items | 74.315 | 44.642 | 34.985 | 15.06 | 12.069 |
Cash Taxes Paid | 29.146 | 21.742 | 9.705 | 12.488 | 12.694 |
Cash Interest Paid | 6.796 | 7.305 | 6.025 | 4.857 | 2.03 |
Changes in Working Capital | -62.008 | -7.572 | -2.004 | 6.305 | -9.617 |
Cash From Investing Activities | -22.832 | -52.199 | -62.189 | -96.871 | -102.656 |
Capital Expenditures | -25.299 | -52.804 | -60.064 | -98.379 | -31.407 |
Other Investing Cash Flow Items, Total | 2.467 | 0.605 | -2.125 | 1.508 | -71.249 |
Cash From Financing Activities | -183.702 | -46.873 | -20.878 | 31.547 | 20.076 |
Financing Cash Flow Items | -6.796 | -7.305 | -6.025 | -4.857 | -2.413 |
Total Cash Dividends Paid | -52.015 | -37.349 | -19.186 | -17.954 | -15.63 |
Issuance (Retirement) of Stock, Net | -18.311 | 2.365 | 0.778 | 0.582 | 0.771 |
Issuance (Retirement) of Debt, Net | -106.58 | -4.584 | 3.555 | 53.776 | 37.348 |
Foreign Exchange Effects | -1.545 | 0.811 | 1.229 | -1.058 | -1.234 |
Net Change in Cash | -11.854 | 61.851 | 51.308 | 44.765 | 7.714 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | |
---|---|---|---|---|---|
Net income/Starting Line | 143.702 | 59.962 | 83.716 | 38.84 | 64.67 |
Cash From Operating Activities | 196.225 | 134.9 | 160.112 | 83.183 | 133.146 |
Cash From Operating Activities | 37.513 | 19.265 | 36.725 | 17.345 | 33.487 |
Amortization | 2.703 | 1.361 | 2.601 | 1.135 | 2.008 |
Non-Cash Items | 74.315 | 27.966 | 44.642 | 18.355 | 34.985 |
Cash Taxes Paid | 29.146 | 14.588 | 21.742 | 11.505 | 9.705 |
Cash Interest Paid | 6.796 | 3.524 | 7.305 | 3.455 | 6.025 |
Changes in Working Capital | -62.008 | 26.346 | -7.572 | 7.508 | -2.004 |
Cash From Investing Activities | -22.832 | -11.363 | -52.199 | -40.441 | -62.189 |
Capital Expenditures | -25.299 | -11.811 | -52.804 | -40.711 | -60.064 |
Other Investing Cash Flow Items, Total | 2.467 | 0.448 | 0.605 | 0.27 | -2.125 |
Cash From Financing Activities | -183.702 | -99.078 | -46.873 | -30.648 | -20.878 |
Financing Cash Flow Items | -6.796 | -3.524 | -7.305 | -3.455 | -6.025 |
Total Cash Dividends Paid | -52.015 | -52.015 | -37.349 | -37.349 | -19.186 |
Issuance (Retirement) of Stock, Net | -18.311 | -19.126 | 2.365 | 2.504 | 0.778 |
Issuance (Retirement) of Debt, Net | -106.58 | -24.413 | -4.584 | 7.652 | 3.555 |
Foreign Exchange Effects | -1.545 | -0.413 | 0.811 | 0.514 | 1.229 |
Net Change in Cash | -11.854 | 24.046 | 61.851 | 12.608 | 51.308 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Raffles Medical Holdings Pte. Ltd. | Corporation | 38.1805 | 719394504 | 0 | 2023-03-21 | LOW |
Loo (Choon Yong) | Individual Investor | 10.7473 | 202500534 | 0 | 2023-03-21 | LOW |
Global Alpha Capital Management Ltd. | Investment Advisor | 8.9571 | 168768350 | 0 | 2023-03-21 | LOW |
S & D Holdings Pte. Ltd. | Corporation | 3.3306 | 62755366 | 0 | 2023-10-05 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.3986 | 26351915 | 187300 | 2023-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.897 | 16901331 | -80493 | 2022-12-31 | LOW |
Tan (Tiang Lee) | Individual Investor | 0.8344 | 15721192 | 304000 | 2023-03-21 | |
Asian Medical Foundation Ltd. | Corporation | 0.7666 | 14443321 | 0 | 2023-03-21 | |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.6348 | 11961100 | 52000 | 2023-09-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.6277 | 11826234 | 65700 | 2023-09-30 | LOW |
Florida State Board of Administration | Pension Fund | 0.5846 | 11014211 | -1268171 | 2022-09-30 | LOW |
Yii (Hee Seng) | Individual Investor | 0.5148 | 9700513 | 0 | 2023-03-21 | |
Tan (Soo Nan) | Individual Investor | 0.2479 | 4671000 | 5000 | 2023-10-05 | LOW |
Baillie Gifford & Co. | Investment Advisor | 0.2461 | 4636995 | 0 | 2023-07-31 | LOW |
Schroder Investment Management (Singapore) Ltd. | Investment Advisor/Hedge Fund | 0.2424 | 4568152 | 0 | 2023-05-31 | LOW |
Public Mutual Berhad | Investment Advisor | 0.2364 | 4455000 | -10000 | 2023-02-28 | LOW |
J O Hambro Capital Management Limited | Investment Advisor/Hedge Fund | 0.2343 | 4413900 | -182100 | 2023-04-30 | MED |
1832 Asset Management L.P. | Investment Advisor | 0.2279 | 4294600 | 0 | 2023-05-31 | LOW |
Manulife Investment Management (North America) Limited | Investment Advisor | 0.2159 | 4067200 | 0 | 2023-09-30 | LOW |
Wee (Beng Geok) | Individual Investor | 0.1892 | 3564000 | -20000 | 2023-03-21 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Raffles Medical Company profile
Track the Raffles Medical share price today and spot the best levels for profitable CFD trades
Raffles Medical Group Ltd is a full spectrum health services company founded in Singapore in 1976. The company served over 2 million clients in 2020 with operations in 14 cities across five countries. As with many other companies, Raffles Medical initially suffered greatly from closures enacted due to the coronavirus pandemic. The company was unable to offer any non-essential health services which form a large part of its revenue.
After an initial period of closures the company was able to devise new income streams through providing Covid testing to migrant workers and other travellers entering the Southeast Asian countries where they have operations. The company is currently the largest private health care services provider in Singapore.
Raffles Medical stock price was listed on the Singapore Stock Exchange mainboard on April 11, 1997 and trades under the ticker symbol BSL. Raffles Medical operates three primary business lines. The first is healthcare, which offers insurance services, pharmaceutical products and services as well as aftercare coverage for patients. The hospital division offers emergency and surgery services as well as medical devices for patient use. Finally the company has an active investment division, primarily dealing with the real estate holdings of the group.
The Raffles Medical (BSL) stock has traded within the 52-week range of S$0.75 - S$1.14 at an average volume of close to 53 million shares per day. The stock began 2021 at S$0.995 before dipping to a low of S$0.925 near the end of January and then rising steadily to S$1.09 by late March.
BSL has a market capitalisation of just over $2 billion Singapore dollars and posted a net income of S$65 million in 2020. Revenues increased to S$568 million in 2020, up 8.8 per cent from the previous year.
The latest BSL stock chart is updated on the SGX as well as on Capital.com. By accessing the live price chart on Capital.com you can view the Raffles Medical Group share price in real time.
You can trade BSL now with CFDs and open a long or short position, depending on whether you feel the price will rise or fall. CFDs allow you to profit from upward or downward fluctuations in the Raffles Medical (SGX) stock price at Capital.com. Track the BSL stock price and include this Singapore-founded multinational medical services company in your investment portfolio.
Industry: | Ambulance & Emergency Services |
585 North Bridge Road
188770
SG
Income Statement
- Annual
- Quarterly
News

December RBA preview: no move expected at the final meeting of 2023
The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.
14:47, 4 December 2023
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs
12:39, 30 November 2023
Euro Zone CPI expected to continue dropping; economists warn about cutting too soon
EZ PI expected to drop further but speed of decline
08:16, 29 November 2023
A weaker Dollar drives gold higher
Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.
13:49, 28 November 2023
Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain
US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.
13:20, 28 November 2023
RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023
The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.
13:04, 28 November 2023
Crude prices slide on OPEC+ uncertainty
Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.
12:55, 28 November 2023People also watch
Still looking for a broker you can trust?
Join the 570.000+ traders worldwide that chose to trade with Capital.com